Back
Cassava Sciences Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
22
SAVA
Cassava Sciences
Last Price:
26.62
Seasonality Move:
36.31%
Buy
54
BMRN
Biomarin Pharmaceutical
Last Price:
66.13
Seasonality Move:
13.3%
Sell
22
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $23.93. The Score for SAVA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- SAVA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $66.04. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $23.93
The current trend is relatively stagnant and SAVA is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.62 | Sell |
| Relative Strength Index (14 RSI): | 34.67 | Sell |
| Chaikin Money Flow: | -1078015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.45 - 28.17) | Sell |
| Bollinger Bands (100): | (16.64 - 30.4) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.96 | Sell |
| Relative Strength Index (14 RSI): | 29.66 | Sell |
| Chaikin Money Flow: | 826493 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.58 - 70.68) | Sell |
| Bollinger Bands (100): | (71.66 - 88.44) | Sell |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.94 | Sell |
| 20-day SMA: | 26.81 | Sell |
| 50-day SMA: | 27.82 | Sell |
| 200-day SMA: | 22.78 | Buy |
| 8-day EMA: | 25.87 | Sell |
| 20-day EMA: | 26.7 | Sell |
| 50-day EMA: | 26.62 | Sell |
| 200-day EMA: | 23.85 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.62 | Sell |
| 20-day SMA: | 69.09 | Sell |
| 50-day SMA: | 74.56 | Sell |
| 200-day SMA: | 82.71 | Sell |
| 8-day EMA: | 67.29 | Sell |
| 20-day EMA: | 68.99 | Sell |
| 50-day EMA: | 73.26 | Sell |
| 200-day EMA: | 81.42 | Sell |
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and a decrease next year of $0.01 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Cassava Sciences Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||